Navigation Links
Ohio State receives $34M NIH grant
Date:5/30/2008

COLUMBUS, Ohio Medical researchers at The Ohio State University, in partnership with Nationwide Children's Hospital, have received a $34 million grant from the National Institutes of Health to create a center to develop clinical and translational protocols that help identify and advance treatments for patients. The grant is one of the largest ever received by Ohio State.

The Ohio State University Center for Clinical and Translational Science will provide support services to Ohio State researchers while fostering collaboration with other medical centers that are grant recipients.

"By facilitating collaborations among university medical centers, this NIH grant assures swift and meaningful advances in patient care," said Ohio State University President E. Gordon Gee. "The approach will accelerate research outcomes at Ohio State and elsewhere, and I am delighted that we are a part of this consortium."

Under the direction of Dr. Rebecca Jackson, professor of internal medicine, an endocrinologist and associate dean for clinical research, the center will leverage expertise from 16 colleges at Ohio State, along with scientists and clinicians at The Ohio State University Medical Center and Nationwide Children's Hospital.

The grant award provides administrative support needed to develop improved methods for analyzing research data and managing clinical trials, allowing for greater community outreach, and creating partnerships in central Ohio and beyond.

"With this award, we are joining a consortium of elite medical centers in developing innovative methods and approaches to research that bring proven treatments more quickly to patients," said Dr. Wiley "Chip" Souba Jr., dean of Ohio State's College of Medicine and interim senior vice president and executive dean for Health Sciences and CEO of the Medical Center. "This award speaks to the quality of our research, training programs, interdisciplinary collaboration, and partnerships with public and private organizations."

By engaging faculty and staff from across Ohio State, the center is creating a collaborative network focusing on science, education, research design and implementation. Additional emphasis is being placed on training the next generation of researchers by utilizing innovative educational initiatives to build their clinical and translational skills, while supporting their career development.

"The opportunities provided by the CTSA are enormously exciting for Ohio State investigators as well as the community," said Jackson. "This grant allows us to develop and refine educational and research approaches in clinical and translational science to enhance the rapid translation of new information to improve human health."

Ohio State is one of 30 medical centers across the country receiving the NIH grant targeted to strengthening clinical and translational science that will lead to better patient care. Administered by the National Center for Research Resources, a component of the NIH, the Clinical and Translational Science Award program funds diverse and far-reaching approaches related to all aspects of research.


'/>"/>

Contact: Doug Flowers
Doug.Flowers@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related medicine news :

1. Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts States Rural Seniors
2. IDC awarded Indias largest state government contract for digital radiography systems
3. NIH awards $25M clinical research grant to Indiana U for statewide initiative
4. PA State Health Officials Encourage Smokers to Quit on World No Tobacco Day
5. Type of Tomato Product Determines Power Against Prostate Cancer
6. Dehydrated tomatoes show promise for preventing prostate cancer
7. States Scorecard Finds Big Differences in Kids Health Care
8. No association found between vitamin D concentration in blood and risk of prostate cancer
9. Vitamin D Status Not Associated With Lower Prostate Risk
10. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
11. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: